Elsa Arribas, M.D.

Peer-Reviewed Articles

1. Weaver OO, Yang WT, Scoggins ME, Adrada BE, Arribas E, Moseley T, Esquivel J, Melgar Y, Kornecki A. Challenging contrast-enhanced mammography-guided biopsies: Practical approach using real-time multimodality imaging and a proposed procedural algorithm. American Journal of Roentgenology 220(4):512-523, 2023. PMID: 36321982.
2. Kuerer HM, Smith BD, Krishnamurthy S, Yang WT, Valero V, Shen Y, Lin H, Lucci A, Boughey JC, White RL, Diego EJ, Rauch GM, on behalf of the Exceptional Responders Clinical Trials Group: Moseley TW, Parra R, Adrada BE, Leung JWT, Sun SX, Teshome M, Miggins MV, Hunt KK, DeSnyder SM, Ehlers RA, Hwang RF, Colen JS, Arribas E, Samiian L, Lesnikoski B, Piotrowski M, Bedrosian I, Chong C, Refinetti AP, Huang M, Candelaria RP, Loveland-Jones C, Mitchell MP, Shaitelman SF. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: A multicentre, single-arm, phase 2 trial. The Lancet Oncology 23(12):1517-1524, 2022.
3. Candelaria RP, Adrada BE, Lane DL, Rauch GM, Moulder SL, Thompson AM, Bassett RL, Arribas EM, Le-Petross HT, Leung JWT, Spak DA, Ravenberg EE, White JB, Valero V, Yang WT. Mid-treatment ultrasound descriptors as qualitative imaging biomarkers of pathologic complete response in patients with triple-negative breast cancer. Ultrasound in Medicine and Biology 48(6):1010-1018, 2022. e-Pub 2022. PMID: 35300879.
4. Huang ML, Hess K, Ma J, Santiago L, Scoggins ME, Arribas E, Adrada BE, Le-Petross HT, Leung JWT, Yang W, Geiser W, Candelaria RP. Prospective comparison of synthesized mammography with DBT and full-field digital mammography with DBT uncovers recall disagreements that may impact cancer detection. Academic Radiology 29(7):1039-1045. e-Pub 2021. PMID: 34538550.
5. Musall BC, Abdelhafez AH, Adrada BE, Candelaria RP, Mohamed RMM, Boge M, Le-Petross H, Arribas E, Lane DL, Spak DA, Leung JWT, Hwang KP, Son JB, Elshafeey NA, Mahmoud HS, Wei P, Sun J, Zhang S, White JB, Ravenberg EE, Litton JK, Damodaran S, Thompson AM, Moulder SL, Yang WT, Pagel MD, Rauch GM, Ma J. Functional tumor volume by fast dynamic contrast-enhanced MRI for predicting neoadjuvant systemic therapy response in triple-negative breast cancer. Journal of Magnetic Resonance Imaging 54(1):251-260, 2021. e-Pub 2021. PMID: 33586845.
6. Santiago L, Volk RJ, Checka CM, Black D, Lee J, Colen JS, Akay C, Caudle A, Kuerer H, Arribas EM. Acceptability of 3D-printed breast models and their impact on the decisional conflict of breast cancer patients: A feasibility study. Journal of Surgical Oncology 123(5):1206-1214, 2021. e-Pub 2021. PMID: 33577715.
7. Guirguis MS, Adrada B, Santiago L, Candelaria R, Arribas E. Mimickers of breast malignancy: Imaging findings, pathologic concordance and clinical management. Insights Imaging 12(53), 2021.
8. Nia ES, Adrada BE, Whitman GJ, Candelaria RP, Krishnamurthy S, Bassett RL, Arribas E. MRI features of pseudoangiomatous stromal hyperplasia with histopathological correlation. The Breast Journal 27(3):242-247, 2021.
9. Roy M, Teshome M, Damodaran S, Sahin AA, Khazai L, Arribas E, Candelaria RP, Scoggins ME, Lane DL, Giordano SH, Albarracin CT, Prieto VG, Nagarajan P. Male mammary paget disease: A tale of 2 contrasting cases. The American Journal of Dermatopathology 42(12):981-985, 2020. PMID: 33289978.
10. Candelaria RP, Adrada BE, Hess K, Santiago L, Lane DL, Thompson AM, Moulder SL, Huang ML, Arribas EM, Rauch GM, Leung JWT, Symmans WF, Valero V, Ravenberg EE, White JB, Yang WT. Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients. European Journal of Radiology 130:109170, 2020. e-Pub 2020. PMID: 32777736.
11. Abdelhafez AH, Musall BC, Adrada BE, Hess K, Son JB, Hwang KP, Candelaria RP, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, Arribas E, Lane DL, Scoggins ME, Leung JWT, Mahmoud HS, White JB, Ravenberg EE, Litton JK, Valero V, Wei P, Thompson AM, Moulder SL, Pagel MD, Ma J, Yang WT, Rauch GM. Tumor necrosis by pretreatment breast MRI: Association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC). Breast Cancer Research Treatment 185(1):1-12. e-Pub 2020. PMID: 32920733.
12. Carr LW, Roberts J, Mericli AF, Liu J, Arribas EM, Clemens MW. Breast implant imaging surveillance among US plastic surgeons: FDA recommendations versus clinical reality. Plastic and Reconstructive Surgery 145(6):1381-1387. e-Pub 2020.
13. DeFazio MV, Arribas EM, Ahmad FI, Le-Petross HT, Liu J, Chu CK, Santiago L, Clemens MW. Application of three-dimensional printed vascular modeling as a perioperative guide to perforator mapping and pedicle Dissection during abdominal flap harvest for breast reconstruction. Journal of Reconstructive Microsurgery 36(5):325-338, 2020. e-Pub 2020. PMID: 32000277.
14. Ballard DH, Sheikh AM, Weadock WJ, Ryan JR, Matsumoto JS, Souza C, Wake N, Levine D, Ghodadra A, Quigley EP, Christensen A, Chepelev L, Althobaithy W, Jeyaraj S, Krivaniak A, Pietila T, Shorti R, Santiago L, Arribas E, Decker S, Parthasarathy J, Witowski J. Radiological Society of North America (RSNA) 3D printing special interest group (SIG) clinical situations for which 3D printing is considered an appropriate representation or extension of data contained in a medical imaging examination: Abdominal, hepatobiliary, and gastrointestinal conditions. 3D Printing in Medicine. e-Pub 2020.
15. Santiago L, Adrada BE, Caudle AS, Clemens MW, Black DM, Arribas EM. The role of 3-dimensional printing in the surgical management of breast cancer. Journal of Surgical Oncology 120(6):897-902, 2019. e-Pub 2019. PMID: 31441070.
16. Candelaria RP, Adrada BE, Wei W, Thompson AM, Santiago L, Lane DL, Huang ML, Arribas EM, Rauch GM, Fraser Symmans W, Gilcrease MZ, Huo L, Lim B, Ueno NT, Moulder SL, Yang WT.. Imaging features of triple-negative breast cancers according to androgen receptor status. European Journal of Radiology 114:167-174, 2019. PMID: 31005169.
17. Chepelev L, Wake N, Ryan J, Althobaity W, Gupta A, Arribas E, Santiago L, Ballard D, Wang K, Weadock W, Ionita C, Mitsouras D, Morris J, Matsumoto J, Christensen A, Liacouras P, Rybicki F, Sheikh A, and RSNA Special Interest Group for 3D Printing. Radiological Society of North America 3D printing special interest group: Guidelines for medical 3D printing and appropriateness for clinical scenarios. 3D Printing in Medicine 4(11), 2018. PMID: 30649688.
18. Yam C, Seth S, Hess K, Mittendorf E, Damodaran S, Helgason T, Thompson L Huo A, Barton M, Huang M, Arribas E, Lane D, Rauch G, Adrada B, Gilcrease Z, Chang T, Moulder S. Impact of clinical, morphologic and molecular characteristic on response to neoadjuvant systemic therapy (NAST) in metaplastic breast cancer (MpBC). Annals of Oncology 29(8), 2018.
19. Rauch GM, Kuerer HM, Adrada B, Santiago L, Moseley T, Candelaria RP, Arribas E, Sun J, Leung JWT, Krishnamurthy S, Yang WT. Biopsy feasibility trial for breast cancer pathologic complete response detection after neoadjuvant chemotherapy: Imaging assessment and correlation endpoints. Annals of Surgical Oncology 25(7):1953-1960, 2018. e-Pub 2018. PMID: 29667115.
20. Speer M, Adrada B, Arribas E, Hess KR, Middleton LP, Whitman G. Imaging of intracystic papillary carcinoma. Current Problems in Diagnostic Radiology 48(4):348-352, 2018. PMID: 30072190.
21. Yam C, Hess K, Litton J, Yang W, Santiago L, Candelaria R, Mittendorf E, Murthy R, Damodaran S, Helgason T, Huo L, Thompson A, Barton M, Huang M, Arribas E, Lane D, Rauch G, Adrada B, Gilcrease M, Moulder S. Impact of metaplastic histology(MpBC) in triple-negative breast cancer patient receiving neoadjuvant systemic therapy. Journal of Clinical Oncology 36(15):593, 2018.
22. Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WT. A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy. Annals of Surgery 267(5):946-951. e-Pub 2017. PMID: 28549010.
23. Adrada B, Huo L, Lane DL, Arribas E, Resetkova E, Yang W. Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer. Annals of Surgical Oncology 22(4):1111-7, 2015. e-Pub 2014. PMID: 25287438.
24. Zhang S, Huo L, Arribas E, Middleton LP. Adenomyoepithelioma of the breast with associated atypical lobular hyperplasia: A previously unrecognized association with management implications. Annals of Diagnostic Pathology 19(1):20-3, 2015. e-Pub 2014. PMID: 25631879.
25. Adrada BE, Miranda RN, Clemens MW, Rauch GM, Arribas E, Fanale M, Haideri N, Mustafa E, Medeiros LJ, Yang W. Breast implant-associated anaplastic large cell lymphoma: Analysis of imaging studies in 44 patients reveals need for systematic assessment of mass versus no mass to improve diagnostic accuracy. Plastic and Reconstructive Surgery 134(4 Suppl 1):95-96, 2014.
26. Adrada BE, Miranda RN, Rauch GM, Arribas E, Kanagal-Shamanna R, Clemens MW, Fanale M, Haideri N, Mustafa E, Larrinaga J, Reisman NR, Jaso J, You MJ, Young KH, Medeiros LJ, Yang W. Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients. Breast Cancer Research and Treatment 147(1):1-14, 2014. e-Pub 2014. PMID: 25073777.
27. Pan J, Dogan BE, Carkaci S, Santiago L, Arribas E, Cantor SB, Wei W, Stafford RJ, Whitman GJ. Comparing performance of the CADstream and the DynaCAD breast MRI CAD Systems: CADstream vs. DynaCAD in breast MRI. Journal of Digital Imaging 26(5):971-6, 2013. e-Pub 2013.
28. Haygood TM, Arribas E, Liu QM, Atkinson EN, Brennan PC, Santiago L, Carkaci S, Lane D, Stephens TW, Le-Petross H, Adrada B, Davis P, Whitman GJ. Detection of microcalcifications on digital screening mammograms using varying degrees of monitor zooming. American Journal of Roentgenology 197(4):W761-8, 2011. PMID: 21940549.
29. Shkumat NA, Springer A, Walker CM, Rohren EM, Yang WT, Adrada BE, Arribas E, Carkaci S, Chuang HH, Santiago L, Mawlawi OR. Investigating the limit of detectability of a positron emission mammography device: A phantom study. Medical Physics 38(9):5176-85, 2011. PMID: 21978062.
30. Resetkova E, Khazai L, Albarracin CT, Arribas E. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast. The Breast Journal 16(6):573-80, 2010. PMID: 21070433.
31. Tchou PM, Haygood TM, Atkinson EN, Stephens TW, Davis PL, Arribas E, Geiser WR, Whitman GJ. Interpretation time of computer-aided detection at screening mammography. Radiology 257(1):40-6, 2010. e-Pub 2010. PMID: 20679448.
32. Haygood TM, Arribas E, Brennan PC, Atkinson EN, Herndon M, Dieber J, Geiser W, Santiago L, Mills CM, Davis P, Adrada B, Carkaci S, Stephens T, Whitman GJ. Conspicuity of microcalcifications on digital screening mammograms using varying degrees of monitor zooming. Academic Radiology 16(12):1509-17, 2009. PMID: 19896068.
33. Adrada B, Arribas E, Gilcrease M, Yang WT. Invasive micropapillary carcinoma of the breast: Mammographic, sonographic, and MRI features. American Journal of Roentgenology 193(1):W58-63, 2009. PMID: 19542384.
34. Lai CJ, Shaw CC, Geiser W, Chen L, Arribas E, Stephens T, Davis PL, Ayyar GP, Dogan BE, Nguyen VA, Whitman GJ, Yang WT. Comparison of slot scanning digital mammography system with full-field digital mammography system. Medical Physics 35(6):2339-46, 2008. PMID: 18649467.
35. Lai CJ, Shaw CC, Whitman GJ, Johnston DA, Yang WT, Selinko V, Arribas E, Dogan B, Kappadath SC. Visibility of simulated microcalcifications--a hardcopy-based comparison of three mammographic systems. Medical Physics 32(1):182-94, 2005. PMID: 15719969.
36. Lutzker S, Le V, Perez-Young I, Arribas E, Ernst R, Kawashima A, Sandler C. A desktop digital imaging and communications in medicine picture archiving and communications system with multiple monitors using Windows '98. Journal of Digital Imaging 12(2 Suppl 1):191, 1999. PMID: 10342208.

Invited Articles

1. Arribas E, Whitman GJ, De Bruhl N. Screening breast ultrasound: Where are we today?. Current Breast Cancer Reports, 2016. e-Pub 2016.
2. Whitman GJ, Arribas E, Uppendahl L. Mammographic-sonographic correlation. Seminars in Roentgenology 46(4):252-9, 2011. PMID: 22035667.

Manuals, Teaching Aids, Other Teaching Publications

1. Abouharb S, Adrada B, Akay C, Albarracin C, Arribas E, Arun BK, Barcenas C, Bast RC, Bedrosian I, Booser DJ. Cancer Treatment Algorithm, Breast Cancer - Metastatic Disease algorithm. The University of Texas MD Anderson Cancer Center, 2022.
2. Abouharb S, Adrada B, Akay C, Albarracin C, Arribas E, Arun B, Barcenas C, Bast R, Bedrosian I, Black S. Cancer treatment algorithms, Breast cancer- invasive stage I-III. The University of Texas MD Anderson Cancer Center, 2021.
3. Abouharb S, Adrada B, Akay C, Albarracin C, Arribas E, Arun B, Barcenas C, Bast R, Bedrosian I, Booser D. Cancer treatment algorithms, Breast cancer- noninvasive. The University of Texas MD Anderson Cancer Center, 2021.
4. Albarracin C, Araujo D, Arribas E, Arun B, Bevers T, Bast R, Bedrosian I, Benjamin R, Booser D, Brewster A. Cancer treatment algorithms, Phyllodes Tumor. The University of Texas MD Anderson Cancer Center, 2021.
5. Albarracin C, Araujo D, Arribas E, Arun B, Babiera G, Bast R, Bedrosian I, Benjamin R, Black S, Booser D, et al.. Practice algorithm for phyllodes tumor. The University of Texas MD Anderson Cancer Center, 2019.
6. Moseley TW, Adrada BE, Arribas EM. Breast cancer noninvasive- documents for clinical scenario appropriate use criteria/ qualified provider-led entity. The University of Texas MD Anderson Cancer Center, 2019.
7. Moseley TW, Adrada BE, Arribas EM. Phyllodes tumors- documents for clinical scenario appropriate use criteria/ qualified provider-led entity. The University of Texas MD Anderson Cancer Center, 2019.
8. Abouharb S, Adrada B, Akay C, Albarracin C, Arribas E, Arun B, Barcenas C, Bast R, Bedrosian I, Booser D, et al.. Practice algorithm for breast cancer – invasive. The University of Texas MD Anderson Cancer Center, 2018.
9. Albarracin C, Ames F, Andreopoulo E, Araujo D, Arribas E, Arun B, Babiera G, Bast R, Bedrosian I, Benjamin R, et al.. Practice algorithm for phyllodes tumor. The University of Texas MD Anderson Cancer Center, 2017.
10. Abouharb S, Adrada B, Albarracin C, Arribas E, Arun B, Barcenas C, Bast R, Babiera G, Bedrosian I, Booser D, et al.. Practice algorithm for breast cancer – noninvasive. The University of Texas MD Anderson Cancer Center, 2017.
11. Albarracin C, Ames F, Andreopoulo E, Araujo D, Arribas E, Arun B, Babiera G, Bast R, Bedrosian I, Benjamin R, et al.. Practice algorithm for phyllodes tumor. The University of Texas MD Anderson Cancer Center, 2012.
12. Albarracin C, Ames F, Andreopoulo E, Araujo D, Arribas E, Arun B, Babiera G, Bast R, Bedrosian I, Benjamin R, et al.. Practice algorithm for phyllodes tumor. The University of Texas MD Anderson Cancer Center, 2011.
13. Albarracin C, Ames F, Andreopoulo E, Araujo D, Arribas E, Arun B, Babiera G, Bast R, Bedrosian I, Benjamin R, et al.. Practice algorithm for phyllodes tumor. The University of Texas MD Anderson Cancer Center, 2010.
14. Albarracin C, Ames F, Andreopoulo E, Araujo D, Arribas E, Arun B, Babiera G, Bast R, Bedrosian I, Benjamin R, et al.. Practice algorithm for phyllodes tumor. The University of Texas MD Anderson Cancer Center, 2009.

Other Articles

1. Unknown 3D-Printed models help support patient decision making. Radiological Society of North America News, 2021.
2. Arribas E, Santiago L, Leung J Three-dimensional printing in medicine, radiology, and breast cancer. Society of Breast Imaging News(2), 2018.

Abstracts

1. Rauch GM, Adrada BE, Candelaria RP, Elshafeey NA, Abdelhafez AH, Musall BC, Sun J, Boge M, Mohamed RMM, Son JB, Zhang S, Leung J, Lane D, Scoggins M, Spak D, Arribas E, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, White JB, Ravenberg E, Hwang K, Wei P, Huo L, Litton JK, Valero V, Tripathy D, Thompson AM, Pagel MD, Ma J, Yang WT, Moulder S. Volumetric changes on longitudinal dynamic contrast enhanced MR imaging (DCE-MRI) as an early treatment response predictor to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients. San Antonio Breast Cancer Symposium, 2020.
2. Adrada BE, Abdelhafez AH, Musall BC, Hess KR, Son JB, Pagel MD, Hwang KP, Candelaria RP, Santiago L, Whitman GJ, Le-Petross H, Moseley TW, Arribas E, Lane DL, Scoggins ME, Spak DA, Leung JWT, Damodaran S, Lim B, Valeo V, White JB, Thompson AM, Litton JK, Moulder SL, Ma J, Yang WT, Rauch GM. Quantitative apparent diffusion coefficient (ADC) radiomics of tumor and peritumoral regions as potential predictors of treatment response to neoadjuvant chemotherapy (NACT) in triple negative breast cancer (TNBC) patients. San Antonio Breast Cancer Symposium, 2019.
3. Abdel Hameed AH, Adrada BE, Musall B, Ma J, Candelaria RP, Yang WT, Hess K, Santiago L, Whitman GJ, Le-Petross HC, Moseley TW, Arribas EM, Lane DL, Scoggins ME, Leung JW, Pagel MD, Hwang KP, Son JB, Litton J, Damodaran S, Lim B, White J, Mahmoud HS, Valero V, Thompson A, Moulder S, Rauch GM. Tumor necrosis at baseline dynamic contrast enhanced (DCE) MRI for prediction of neoadjuvant chemotherapy treatment (NACT) response in triple negative breast cancer (TNBC) patients. Radiological Society of North America Scientific Assembly and Annual Meeting, 2019.
4. Musall B, Ma J, Adrada BE, Abdel Hameed AH, Candelaria RP, Yang WT, Hess K, Santiago L, Whitman GJ, Le-Petross HC, Moseley TW, Arribas EM, Lane DL, Leung JW, Scoggins ME, Pagel MD, Hwang KP, Son JB, White J, Litton J, Damodaran S, Lim B, Willis B, Mahmoud HS, Megahed AA, Thompson A, S Moulder, Rauch GM. Quantitative tumor volumes by fast dynamic contrast enhanced (DCE) MRI predict pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) in triple negative breast cancer (TNBC). Radiological Society of North America Scientific Assembly and Annual Meeting, 2019.
5. Adrada BE, Candelaria RP, Hess K, Moulder S, Santiago L, Valero V, Arribas EM, Moseley TW, Lane DL, Scoggins ME, Le-Petross HC, Spak DA, Huang ML, Litton J, Thompson AM, White J, Whitman GJ, Leung JW, Yang WT, Rauch GM. Precision imaging: Early ultrasound evaluation (US) to identify excellent responders to neoadjuvant chemotherapy (NAC) in patients (pts) with triple negative breast cancer (TNBC). Radiological Society of North America Scientific Assembly and Annual Meeting, 2019.
6. Candelaria RP, Hess K, Lane DL, Santiago L, Moulder S, Yang WT, Thompson AM, Rauch GM, Huang ML, Arribas EM, Scoggins ME, Moseley TW, Le-Petross HC, Spak DA, Whitman GJ, Leung JW, Valero V, Damodaran S, Litton J, White J, Adrada BE. Predicting pathologic complete response with ultrasound tumor characteristics in triple negative breast cancer patients. Radiological Society of North America Scientific Assembly and Annual Meeting, 2019.
7. Roy M, Sahin AA, Teshome M, Damodaran S, Arribas E , Candelaria R, Albarracin CT, Tetzlaff MT, Curry JL, Aung PP, Torres-Cabala CA, Ivan DS, Prieto VG, Nagarajan P.. Clinically silent male mammary paget disease. The American Society of Dermatopathology 56th Annual Meeting, 2019.